Innate Pharma (IPHA) Total Current Liabilities (2017 - 2026)
Innate Pharma's Total Current Liabilities came in at $38.19 million for the quarter ended Jun 30, 2026, up 14.7% from $33.31 million a year earlier.
Powered by 
Analysis
Innate Pharma (IPHA) Total Current Liabilities (2017 - 2026) Analysis & Trends
As of Dec 31, 2025, Innate Pharma's Total Current Liabilities was $41.41 million, up 16.0% from the prior year.
- Total Current Liabilities carries a five-year compound annual growth rate of -4.4% (years ended Dec 2020 to Dec 2025).
- Going back by year, Total Current Liabilities was $35.7 million in the year ended Dec 31, 2024 (-16.7%), $42.87 million in the year ended Dec 31, 2023 (-1.6%), $43.57 million in the year ended Dec 31, 2022 (-52.3%) and $91.39 million in the year ended Dec 31, 2021 (+76.0%).
- The five-year range for quarterly Total Current Liabilities is $33.31 million (the quarter ended Jun 30, 2025) to $91.39 million (the quarter ended Dec 31, 2021).
- Year-over-year, Total Current Liabilities increased in two of the last four quarters, with an average decline of 0.2%.
- The fastest year-over-year change in Total Current Liabilities over five years came in the quarter ended Dec 31, 2021 (growth of 68.5%), and the weakest in the quarter ended Dec 31, 2022 (a decline of 53.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 47.74 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 54.90 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 41.64 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 27.73 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 31.75 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 31.55 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 25.50 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 11.02 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 32.65 Bn |
| 10 | Innate Pharma | 142.45 Mn | -64.75 Mn | - | 37.53 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 37.53 Mn |
| Dec 31, 2025 | 43.05 Mn |
| Jun 30, 2025 | 34.51 Mn |
| Dec 31, 2024 | 34.32 Mn |
| Jun 30, 2024 | 40.93 Mn |
| Dec 31, 2023 | 43.87 Mn |
| Jun 30, 2023 | 40.94 Mn |
| Dec 31, 2022 | 44.07 Mn |
| Jun 30, 2022 | 76.85 Mn |
| Dec 31, 2021 | 90.47 Mn |
| Jun 30, 2021 | 50.72 Mn |
| Dec 31, 2020 | 55.95 Mn |
| Jun 30, 2020 | 92.62 Mn |
| Dec 31, 2019 | 136.47 Mn |
| Dec 31, 2018 | 225.07 Mn |
| Dec 31, 2017 | 88.26 Mn |
API Access
Innate Pharma Total Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=IPHA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-current-liabilities", "ticker": "IPHA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=IPHA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();